©The Author(s) 2016.
World J Gastroenterol. Nov 14, 2016; 22(42): 9378-9386
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9378
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9378
Table 1 Patient characteristics n (%)
| Characteristics | Patients |
| Sexe | |
| Male | 34 (67.3) |
| Female | 18 (32.7) |
| Age | |
| < 80 | 9 (17.0) |
| ≥ 80 | 43 (83.0) |
| Tumor location | |
| Colorectal | 34 (65.4) |
| Pancreas | 18 (34.6) |
| Metastasis | |
| ≤ 1 | 26 (50.0) |
| > 1 | 26 (50.0) |
| ECOG performance status | |
| [0-1] | 43 (82.7) |
| [2-3] | 9 (17.3) |
| Comorbidities | |
| No | 15 (28.8) |
| Yes | 37 (71.2) |
| Cardiac comorbidities | |
| No | 40 (76.9) |
| Yes | 12 (23.1) |
| Pulmonary comorbidities | |
| No | 47 (90.4) |
| Yes | 5 (9.6) |
| Hepatic comorbidities | |
| No | 52 (100.0) |
| Yes | 0 (0.0) |
| Albumin level | |
| < 30 g/L | 16 (30.8) |
| ≥ 30 g/L | 21 (40.4) |
| Number of usual drugs | |
| < 3 | 22 (42.3) |
| ≥ 4 | 30 (57.7) |
| Charlson comorbidities index | |
| < 10 | 32 (61.5) |
| ≥ 10 | 20 (38.5) |
| Initial autonomy | |
| No | 3 (5.8) |
| Yes | 49 (94.2) |
- Citation: Guion-Dusserre JF, Bertaut A, Ghiringhelli F, Vincent J, Quipourt V, Marilier S, Tharin Z, Bengrine-Lefevre L. Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy. World J Gastroenterol 2016; 22(42): 9378-9386
- URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9378.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i42.9378